GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » PB Ratio

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) PB Ratio : 2.21 (As of May. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-25), GlaxoSmithKline Consumer Nigeria's share price is ₦17.00. GlaxoSmithKline Consumer Nigeria's Book Value per Share for the quarter that ended in Jun. 2023 was ₦7.71. Hence, GlaxoSmithKline Consumer Nigeria's PB Ratio of today is 2.21.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's PB Ratio or its related term are showing as below:

NSA:GLAXOSMITH' s PB Ratio Range Over the Past 10 Years
Min: 0.45   Med: 1.48   Max: 5.52
Current: 2.21

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest PB Ratio was 5.52. The lowest was 0.45. And the median was 1.48.

NSA:GLAXOSMITH's PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2 vs NSA:GLAXOSMITH: 2.21

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Book Value Per Share Growth Rate was -2.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -3.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 18.40% per year. The lowest was -19.00% per year. And the median was 1.70% per year.

Back to Basics: PB Ratio


GlaxoSmithKline Consumer Nigeria PB Ratio Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria PB Ratio Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.96 0.80 0.90 0.77 0.77

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.85 0.72 0.77 0.96

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's PB Ratio

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's PB Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's PB Ratio falls into.



GlaxoSmithKline Consumer Nigeria PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

GlaxoSmithKline Consumer Nigeria's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=17.00/7.705
=2.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


GlaxoSmithKline Consumer Nigeria PB Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines